Clik here to view.
RF IDeas Appoints Nicholas Low as Regional Sales Director for Asia Pacific...
ROLLING MEADOWS, Ill. RF IDeas, Inc. a leading innovator and manufacturer of employee badge readers for in-building applications such as computer access, identification and secure print, today...
View ArticleClik here to view.
RF Ideasがニコラス・ローをアジア太平洋地域販売担当ディレクターに任命
米イリノイ州ローリングメドーズ （ビジネスワイヤ） — コンピューター利用、ID確認、セキュリティーが確保された印刷などの屋内アプリケーション向けに従業員バッジリーダーを手掛ける一流の革新・開発企業RF...
View ArticleClik here to view.
RF IDeas任命Nicholas Low担任亚太区域销售总监
伊利诺伊州罗林梅多斯 (美国商业资讯)–内置应用（例如计算机访问、识别和安全打印）员工卡读卡器领域的领军企业RF IDeas, Inc.今日宣布，任命Nicholas Low担任亚太区域销售总监，此项任命立即生效。Nick将常驻新加坡，执掌该区域的业务开发，重点专注于开发新的原始设备制造商(OEM)业务。此外，Nick还将负责策略销售活动，以提振新市场的渠道开发。 RF...
View ArticleClik here to view.
RenalGuard System Demonstrates Promising Results from First-in-Man Studies to...
MILFORD, Mass. RenalGuard Solutions™, Inc., a medical device company focused on innovative technologies for the cardiac and vascular markets, today reported positive results from a first-in-man...
View ArticleClik here to view.
Generex Confirms Receipt of $700,000 USD License Fee from Shenzhen BioScien...
MIRAMAR, Fla. Generex Biotechnology Corporation (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) (www.generex.com) today confirmed its receipt of the $700,000 USD up-front license fee (net...
View ArticleClik here to view.
Dr. Xiaoxiang Chen Joins Harbour BioMed as Executive Vice President, Head of...
SHANGHAI, ROTTERDAM, The Netherlands & CAMBRIDGE, Mass. Harbour BioMed announced today the appointment of Dr. Xiaoxiang Chen as Executive Vice President, Head of Clinical Development and...
View ArticleClik here to view.
和铂医药宣布任命陈小祥为和铂医药执行副总裁，临床开发和注册科学负责人
中国上海，荷兰鹿特丹和美国马萨诸塞州 和铂医药（Harbour BioMed）宣布，任命陈小祥医师为执行副总裁，临床开发和注册科学负责人。 本新闻稿包含多媒体。此处查看新闻稿全文： http://www.businesswire.com/news/home/20180103005373/zh-CN/ 陈小祥医师，和铂医药执行副总裁，临床开发和注册科学负责人 (照片：美国商业资讯)...
View ArticleClik here to view.
Masimo宣布氧储备指数™ rainbow Lite传感器获得CE标记并开始发售
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，RD rainbow Lite SET™传感器已获得CE标记并开始发售，该传感器可实现Masimo氧储备指数™ (ORi™)和RPVi™的监测，后者是一种改良的PVi®，允许临床工作者以无创方式连续评估体液应答性1，成本仅有创伤性方法和rainbow®传感器的一个零头。rainbow...
View ArticleClik here to view.
RenalGuard Systemが心不全患者を対象とする技術評価のヒト初回試験で有望な結果を実証
米マサチューセッツ州ミルフォード （ビジネスワイヤ） — 心血管疾患市場向けの革新的な技術に傾注する医療機器企業のリーナルガード・ソリューションズは本日、体液過剰を伴ううっ血性心不全の患者を対象とする利尿薬療法の体液管理でRenalGuard System®の新規使用を検討するヒト初回実現可能性試験について、良好な結果を報告しました。結果は最近、ドイツのベルリンで開催された年次Devices...
View ArticleClik here to view.
Illumina and KingMed Diagnostics Partner to Develop Next-Generation...
SAN DIEGO Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing...
View ArticleClik here to view.
SanBio Primary Researcher Receives 2017 Smithsonian American Ingenuity Award
MOUNTAIN VIEW, Calif. SanBio, Inc., a leader in regenerative cell therapies for neurological disorders, joins the Smithsonian Institution in recognizing Stanford University’s Dr. Gary Steinberg,...
View ArticleClik here to view.
Canon Announces Corporate Name Change of Toshiba Medical Systems Corporation...
TOKYO Canon Inc. and Canon Medical Systems Corporation today announced the official corporate name (trade name) change of Canon Group Company Toshiba Medical Systems Corporation to Canon Medical...
View ArticleClik here to view.
マシモが予備酸素摂量指数を測定できるrainbow LiteセンサーのCEマーク取得と発売を発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、RD rainbow Lite SET™センサーのCEマーク取得と発売を発表しました。これらのセンサーにより、マシモの予備酸素摂量指数（Oxygen Reserve...
View ArticleClik here to view.
Fierce创新奖决胜者HeartSciences将出席2018年1月9日和10日在旧金山召开的生物技术展演活动
德克萨斯州南湖 (美国商业资讯) — 医疗器械公司HeartSciences最近入选为Fierce创新奖(Fierce Innovation Awards)数码医疗解决方案类别的决胜者，该公司将出席在旧金山召开的生物技术展演。HeartSciences已预订两场呈报：(1) 1月9日星期二下午2:45在联合广场希尔顿酒店召开的生物技术展演，(2) 1月10日星期三上午10:00在Parc...
View ArticleClik here to view.
Takeda and Denali Therapeutics Collaborate to Develop and Commercialize...
OSAKA, Japan & SOUTH SAN FRANCISCO, CA Takeda Pharmaceutical Company Limited (TSE: 4502) and Denali Therapeutics (NASDAQ: DNLI) today announced that they have entered into a strategic option and...
View ArticleClik here to view.
Jiangsu Hengrui Medicine and Arcutis Announce a Development and...
SHANGHAI & MENLO PARK, Calif. Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276), a fully integrated biopharmaceutical company based in Shanghai, and Arcutis, Inc., a biotechnology company based...
View ArticleClik here to view.
KBP Biosciences Raises $76 Million in Series A Financing and Appoints Brian...
JINAN, China & PHILADELPHIA KBP Biosciences, a private clinical-stage biotechnology company dedicated to the research, development and commercialization of innovative medicines in areas of unmet...
View ArticleClik here to view.
フィアース・イノベーション・アワーズ最終選考企業のハートサイエンシズが2018年1月9日と10日のサンフランシスコでのバイオテック・ショーケース・イベント...
米テキサス州サウスレイク （ビジネスワイヤ） —...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Limited to Present at the 36th Annual J.P. Morgan...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd (BSE: 500124)(NSE: DRREDDY)(NYSE: RDY) announced that the Company will be presenting at the 36th Annual J.P. Morgan Healthcare...
View ArticleClik here to view.
Elastagen to Feature Breakthrough Tissue Repair and Aesthetic Platform at...
SYDNEY Elastagen, a clinical-stage medical technology company with an advanced tissue repair platform based on tropoelastin, today announced that it will showcase the latest clinical developments...
View Article